Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
|
|
KalVista Pharmaceuticals, Inc. (KALV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
4
| Unkart Edward W (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $10.08, valued at
$100.8k
|
|
| 09/28/2023 |
4
| Pereira Brian JG (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $10.08, valued at
$100.8k
|
|
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2023 |
4
| Audhya Paul K. (Chief Medical Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 8,020 shares
@ $10.7288, valued at
$86k
Exercised 2,418 restricted stock units
@ $0
Exercised 4,028 restricted stock units
@ $0
Exercised 12,083 rights
@ $0 |
|
| 08/21/2023 |
4
| Feener Edward P. (Chief Scientific Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 4,976 shares
@ $10.7287, valued at
$53.4k
Exercised 1,773 restricted stock units
@ $0
Exercised 2,430 restricted stock units
@ $0
Exercised 7,291 rights
@ $0 |
|
| 08/21/2023 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 7,142 shares
@ $10.7287, valued at
$76.6k
Exercised 1,773 restricted stock units
@ $0
Exercised 2,430 restricted stock units
@ $0
Exercised 7,291 rights
@ $0 |
|
| 08/21/2023 |
4
| Palleiko Benjamin L (President, CFO, CBO & Sec'y) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 13,067 shares
@ $10.7287, valued at
$140.2k
Exercised 6,944 restricted stock units
@ $0
Exercised 2,418 restricted stock units
@ $0
Exercised 20,833 rights
@ $0 |
|
| 08/21/2023 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 14,876 shares
@ $10.7288, valued at
$159.6k
Exercised 6,944 restricted stock units
@ $0
Exercised 5,805 restricted stock units
@ $0
Exercised 20,833 rights
@ $0 |
|
| 05/22/2023 |
4
| Palleiko Benjamin L (President, CFO, CBO & Sec'y) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $10.4, valued at
$416k
|
|
| 05/19/2023 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 2,604 shares
@ $10.1444, valued at
$26.4k
Granted 29,166 restricted stock units
@ $0
Exercised 2,431 restricted stock units
@ $0
Exercised 1,774 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Palleiko Benjamin L (President, CFO, CBO & Sec'y) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 4,037 shares
@ $10.1444, valued at
$41k
Granted 83,334 restricted stock units
@ $0
Exercised 6,945 restricted stock units
@ $0
Exercised 2,419 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Feener Edward P. (Chief Scientific Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 1,786 shares
@ $10.1444, valued at
$18.1k
Granted 29,166 restricted stock units
@ $0
Exercised 2,431 restricted stock units
@ $0
Exercised 1,774 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 5,627 shares
@ $10.1444, valued at
$57.1k
Granted 83,334 restricted stock units
@ $0
Exercised 6,945 restricted stock units
@ $0
Exercised 5,805 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Audhya Paul K. (Chief Medical Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 2,780 shares
@ $10.1444, valued at
$28.2k
Granted 48,334 restricted stock units
@ $0
Exercised 4,028 options to buy
@ $0
Exercised 2,419 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Audhya Paul K. (Chief Medical Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 3,412 shares
@ $7.66, valued at
$26.1k
Exercised 4,027 options to buy
@ $0
Exercised 2,419 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Feener Edward P. (Chief Scientific Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 2,228 shares
@ $7.66, valued at
$17.1k
Exercised 2,430 options to buy
@ $0
Exercised 1,774 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 2,727 shares
@ $7.66, valued at
$20.9k
Exercised 2,430 options to buy
@ $0
Exercised 1,774 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Palleiko Benjamin L (President, CFO, CBO & Sec'y) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 4,954 shares
@ $7.66, valued at
$37.9k
Exercised 6,944 options to buy
@ $0
Exercised 2,419 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 6,700 shares
@ $7.66, valued at
$51.3k
Exercised 6,944 options to buy
@ $0
Exercised 5,805 restricted stock units
@ $0 |
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Stuart Nancy (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $4.53, valued at
$45.3k
|
|
| 10/17/2022 |
4
| Unkart Edward W (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $4.53, valued at
$45.3k
|
|
| 10/17/2022 |
4
| Pereira Brian JG (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $4.53, valued at
$45.3k
|
|
| 10/17/2022 |
4
| Cha Albert (Director) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $4.53, valued at
$45.3k
|
|
| 09/07/2022 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Gifted 6,500 shares
@ $0
Sold 1,320 shares
@ $17.0134, valued at
$22.5k
|
|
| 08/19/2022 |
4
| Audhya Paul K. (Chief Medical Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 725 shares
@ $14.9615, valued at
$10.8k
Exercised 2,418 restricted stock units
@ $0 |
|
| 08/19/2022 |
4
| Feener Edward P. (Chief Scientific Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 532 shares
@ $14.9619, valued at
$8k
Exercised 1,773 restricted stock units
@ $0 |
|
| 08/19/2022 |
4
| Yea Christopher (Chief Development Officer) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 1,145 shares
@ $14.9607, valued at
$17.1k
Exercised 1,773 restricted stock units
@ $0 |
|
|
|
|